mk8226
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2010 (NCT01096160)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Thymic stromal lymphopoietinANTAGONIST
TSLP antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mk8226
- mk-8226
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01732510 | Phase 1 | Dec 1, 2012 | Merck |
| NCT01096160 | Phase 1 | Mar 1, 2010 | Merck |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 2 | 2 | 1 | 2010 |
1 organizations
Page 1 / 1